Drugs / Tegafur/uracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03161548 | Jul 2011 → Jan 2016 | chemotherapy-induced toxicity, tongue cancer | Taipei Veterans General Hospital, Taiwan | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tegafur/uracil | “Oral tegafur/uracil 300 mg/m2/day plus leucovorin 90 mg/day on days 1 - 14” NCT03161548 ↗ |
| Known as | UFUR | “Tegafur/uracil (UFUR) 200 mg po bid for whole course of radiotherapy” NCT03161548 ↗ |
| Route | Oral | “Tegafur/uracil (UFUR) 200 mg po bid for whole course of radiotherapy” NCT03161548 ↗ |